Inicio › Melanoma › California › San Francisco
Ensayos clínicos de Melanoma en San Francisco, CA
22 estudios para Melanoma buscan participantes en centros de San Francisco y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)
ReclutandoFase 2
- UCSF Medical Center at Mission Bay ( Site 4044), San Francisco
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
ReclutandoFase 3
- University of California San Francisco (UCSF), San Francisco
Intratumoral N17350 in Advanced Solid Tumors
ReclutandoFase 1/2
- University of California, San Francisco, San Francisco
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
ReclutandoFase 2
- Local Institution - 0096, San Francisco
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
ReclutandoFase 1/2
- University of California-San Fransisco, San Francisco
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
ReclutandoFase 1
- University of California San Francisco, San Francisco
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
ReclutandoFase 1/2
- University of California San Francisco, San Francisco
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
ReclutandoFase 1/2
- UCSF Medical Center-Mission Bay, San Francisco
Project: Every Child for Younger Patients With Cancer
ReclutandoEstudio observacional
- UCSF Medical Center-Mission Bay, San Francisco
Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma
ReclutandoFase 2
- University of California, San Francisco, San Francisco
Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors
ReclutandoFase 1/2
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Neoadjuvant Darovasertib in Primary Uveal Melanoma
ReclutandoFase 3
- UCSF Wayne and Gladys Valley Center for Vision, San Francisco
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Reclutando
- Zuckerberg San Francisco General, San Francisco
- Kaiser Foundation Research Institute, San Francisco
- University of San Francisco, San Francisco
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
ReclutandoFase 1/2
- University of California San Francisco (UCSF), San Francisco
A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
ReclutandoFase 2/3
- UCSF, San Francisco
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
ReclutandoFase 1
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
ReclutandoEstudio observacional
- Kaiser Permanente-San Francisco, San Francisco
ACTengine® IMA203 Combined With mRNA-4203
ReclutandoFase 1
- University of California San Francisco, San Francisco
Mirdametinib in Patients With Advanced NF1-mutant Melanoma
ReclutandoFase 2
- California Pacific Medical Center - Sutter Health, San Francisco
Symptoms of Immune Checkpoint Inhibitor Therapy in Cutaneous Melanoma
ReclutandoEstudio observacional
- University of California, San Francisco, San Francisco
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutandoEstudio observacional
- Massive Bio SYNERGY-AI site, San Francisco
A Study of IBI363 in Subjects with Advanced Solid Malignancies
ReclutandoFase 2
- University of California, San Francisco (UCSF), San Francisco
Más información sobre Melanoma en MedlinePlus
Ensayos de Melanoma en otras ciudades
- Houston, TX59 estudios
- New York City, NY38 estudios
- Los Angeles, CA34 estudios
- Nashville, TN33 estudios
- Pittsburgh, PA31 estudios
- Boston, MA26 estudios
- Philadelphia, PA23 estudios
- Atlanta, GA21 estudios
- Durham, NC21 estudios
- St. Louis, MO21 estudios
- Columbus, OH21 estudios
- Salt Lake City, UT21 estudios
Otros estudios en San Francisco
- Cáncer de próstata45 estudios
- Cáncer de seno43 estudios
- Cáncer de pulmón de células no pequeñas36 estudios
- Cáncer (todos los tipos)35 estudios
- Fallo cardíaco29 estudios
- Cáncer metastásico28 estudios
- Cáncer de pulmón23 estudios
- Cáncer de páncreas20 estudios
- Cáncer de ovario19 estudios
- Cáncer del colon y del recto18 estudios
- Enfermedad cardiovascular18 estudios
- Glioblastoma17 estudios
De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.